Completed PHASE4 INTERVENTIONAL 2-arm NCT00509392

ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study. (RECOVERY)

Radiofrequency Endovenous ClosureFAST vs. Laser Ablation for the Treatment of Great Saphenous Reflux: A Multicenter, Single-Blinded, Randomized Study (RECOVERY)

Sponsor: Medtronic Endovascular

Conditions Venous Reflux

Interventions Endovenous Laser Seg. RF Ablation & ClosureFAST catheter

Updated 9 times since 2017 Last updated: Jun 13, 2017 Started: Mar 31, 2007 Primary completion: Jan 31, 2008 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Venous Reflux, this trial is completed. The trial is conducted by Medtronic Endovascular and has accumulated 9 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Aug 2017 — Jun 2018 [monthly]

Completed PHASE4
Feb 2017 — Aug 2017 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic Endovascular
VNUS Medical Technologies, A Covidien Company

Data source: Medtronic Endovascular

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Portland, United States